Community technical support mailing list was retired 2010 and replaced with a professional technical support team. For assistance please contact: Pre-sales Technical support via email to firstname.lastname@example.org.
> 6) A truly visual and robust Release Manager that supports Unix Try CruiseControl, available both in Java and thus running on any OS, or in a .NET clone. It's open source, not much visual, but it won't just release your code. It will check it out, compile it, run tests, tag your repository and move the result where you like. We're using CruiseControl.NET and although its XML-based configuration script it's not the easiest configuration to perform, it works well. If you need a visual and robust release manager under Windows there are excellent tools like AutomatedBuild Studio or FinalBuilder, just to name two (don't know about FreeBSD, sorry, "visual" and "Unix" are often an oxymoron...). Again, if I have to pay money I may prefer a tool that not only does not bind us to a single SCM, but offers greater flexibility, unless the tool that comes with the SCM really outperforms what's available elsewhere, is highly integrated or is really cheap. If I were March-Hare I'd focus on the server (they're doing it already with evs, maybe they could some features in the paid version only), and a good client (multiplatform, if needed), instead of adding three different clients, two of which open source. On this core they could build a suite of SCM software, but looking at what's available on the market - to be really competitive. Right now what's available in the CVS Suite can be easily built with open source tools - and remember most CVSNT customers are developers, they can easily tweak Mantis or write a trigger to get things done - up to modify open source code if neeeded. In our stack right now CVSNT is just the code repository - I may prefer to change it than changing the whole stack above that works well and does not requires CVSNT - alternatives are available. If you are willing to pay, the market often offers more powerful tools - and it looks March-Hare does not take it into account. I understand that if every CVS user starts to pay for it today March-Hare could build great tools tomorrow, but we are users, not investors. We pay for what you offer now, not tomorrow. Sorry. -- Luigi D. Sandon